Clinical Trials Sponsored by Covance Laboratories, Inc
Total 439 results
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Anesiva, Inc.CovanceTerminatedIntravenous Placement Procedure
-
HiberCell, Inc.CovanceCompletedRenal Cell Carcinoma | Gastric Cancer | Metastatic Breast Cancer | Small-cell Lung Cancer | Other Solid TumorsUnited States
-
Aeromics, Inc.CovanceCompleted
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
Aptabio Therapeutics, Inc.CovanceTerminated
-
Bridge Biotherapeutics, Inc.CovanceCompletedUlcerative ColitisUnited States, Korea, Republic of, Poland, Ukraine
-
Anthos Therapeutics, Inc.CovanceCompletedAtrial FibrillationUnited States
-
Bridge Biotherapeutics, Inc.CovanceTerminatedUlcerative ColitisNew Zealand
-
Eisai Inc.PPD; CovanceCompletedAngioplasty | Coronary Catheterization
-
Impact Therapeutics, Inc.CovanceRecruitingAdvanced Solid TumorsUnited States, Taiwan, China
-
Emalex Biosciences Inc.CovanceCompletedHealthy VolunteerUnited Kingdom
-
Matinas Biopharma, IncCovanceWithdrawn
-
Cascade Pharmaceuticals, IncCovanceCompletedPrimary Sclerosing Cholangitis (PSC)United States
-
Enanta Pharmaceuticals, IncCovanceCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Eisai Inc.PPD; CovanceTerminatedOsteotomy | Carpal Tunnel | Arthroscopy | Bunionectomy
-
Iovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Unresectable MelanomaUnited States, Spain, Australia, France, Netherlands, Italy, Canada, Sweden
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Stage IV Non-small Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
Iovance Biotherapeutics, Inc.RecruitingCervical CarcinomaUnited States, Spain, United Kingdom, Germany, France, Italy, Netherlands, Switzerland
-
Iovance Biotherapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Iovance Biotherapeutics, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Iovance Biotherapeutics, Inc.WithdrawnNon Small Cell Lung CancerUnited States
-
Iovance Biotherapeutics, Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States, Canada, Germany, Netherlands, Switzerland
-
Iovance Biotherapeutics, Inc.RecruitingSquamous Cell Carcinoma of the Head and Neck | Metastatic Melanoma | Non-small Cell Lung CancerUnited States, Spain, Canada, France, Germany, Greece, Switzerland, United Kingdom
-
Iovance Biotherapeutics, Inc.No longer availableMetastatic Melanoma | Unresectable MelanomaUnited States
-
Atossa Therapeutics, Inc.Covance; Illumina, Inc.CompletedBreast Cancer | Ductal Carcinoma in Situ | Preneoplastic ConditionsUnited States
-
Hill Dermaceuticals, Inc.Covance; Synteract, Inc.TerminatedAtopic DermatitisUnited States
-
BeyondSpring Pharmaceuticals Inc.Covance; ICON plcCompletedChemotherapy-induced NeutropeniaChina, Russian Federation, United States, Ukraine
-
Par Pharmaceutical, Inc.Covance; SFBC AnapharmTerminated
-
Otsuka Pharmaceutical Development & Commercialization...CovanceCompletedSchizophreniaSpain, Korea, Republic of, United States, Russian Federation, Chile, Estonia, Finland, Mexico, Hungary, Bulgaria, Croatia, Serbia, France, Poland, Romania, Thailand, Puerto Rico, Slovakia, Taiwan, Australia, India, Argentina, South... and more
-
R.J. Reynolds Tobacco CompanyUniversity of Louisville; Covance; Analytisch-biologisches Forschungslabor GmbH; Arista Laboratories and other collaboratorsCompletedCigarette SmokingUnited States
-
Gilead SciencesCovance; ClinPhone, Inc.; Chiltern International Inc.CompletedCystic FibrosisBelgium, France, Germany, Italy, Netherlands, Spain, United States, Ireland, United Kingdom, Portugal, Austria, Denmark, Switzerland
-
Revance Therapeutics, Inc.RecruitingGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedPlantar FasciitisUnited States
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Revance Therapeutics, Inc.Completed
-
Revance Therapeutics, Inc.CompletedSkin AgingUnited States
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedPlantar FasciitisUnited States
-
Revance Therapeutics, Inc.CompletedFrown LinesUnited States, Canada
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Revance Therapeutics, Inc.Active, not recruiting
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States
-
Revance Therapeutics, Inc.CompletedLateral Canthal LinesUnited States
-
Revance Therapeutics, Inc.CompletedTorticollis (Spasmodic)United States
-
Revance Therapeutics, Inc.CompletedSkin AgingUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
Revance Therapeutics, Inc.CompletedFacial Wrinkles | Lateral Canthal Lines | Crow's FeetUnited States